William Blair & Company
CME icon

William Blair & Company’s CME Group CME Stock Holding History

William Blair & Company’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.4M Buy
204,534
+56,694
+38% +$16.8M 0.17% 125
2025
Q4 		$40.4M Buy
147,840
+1,208
+0.8% +$328K 0.11% 157
2025
Q3 		$39.6M Buy
146,632
+3,227
+2% +$878K 0.11% 159
2025
Q2 		$39.5M Sell
143,405
-1,220
-0.8% -$332K 0.11% 160
2025
Q1 		$38.4M Buy
144,625
+1,241
+0.9% +$306K 0.12% 160
2024
Q4 		$33.3M Sell
143,384
-29,167
-17% -$6.71M 0.1% 177
2024
Q3 		$38.1M Sell
172,551
-15,596
-8% -$3.23M 0.11% 152
2024
Q2 		$37M Sell
188,147
-21,306
-10% -$4.4M 0.11% 149
2024
Q1 		$45.1M Buy
209,453
+2,683
+1% +$564K 0.14% 128
2023
Q4 		$43.5M Sell
206,770
-25
-0% -$5.33K 0.15% 132
2023
Q3 		$41.4M Buy
206,795
+810
+0.4% +$161K 0.16% 126
2023
Q2 		$38.2M Buy
205,985
+1,090
+0.5% +$201K 0.14% 138
2023
Q1 		$39.2M Sell
204,895
-1,835
-0.9% -$332K 0.16% 131
2022
Q4 		$34.8M Sell
206,730
-8,689
-4% -$1.51M 0.15% 133
2022
Q3 		$38.2M Buy
215,419
+5,108
+2% +$1.01M 0.18% 126
2022
Q2 		$43.1M Sell
210,311
-4,492
-2% -$952K 0.19% 118
2022
Q1 		$51.1M Buy
214,803
+7,967
+4% +$1.87M 0.18% 123
2021
Q4 		$47.3M Buy
206,836
+19,070
+10% +$4.2M 0.15% 139
2021
Q3 		$36.3M Buy
187,766
+33,007
+21% +$6.69M 0.12% 162
2021
Q2 		$32.9M Buy
154,759
+279
+0.2% +$58.9K 0.11% 168
2021
Q1 		$31.5M Sell
154,480
-17,129
-10% -$3.37M 0.12% 164
2020
Q4 		$31.2M Buy
171,609
+23,445
+16% +$3.99M 0.11% 166
2020
Q3 		$24.8M Sell
148,164
-6,300
-4% -$1.06M 0.11% 171
2020
Q2 		$25.1M Sell
154,464
-5,905
-4% -$1.06M 0.12% 155
2020
Q1 		$27.7M Sell
160,369
-6,219
-4% -$1.24M 0.17% 125
2019
Q4 		$33.4M Buy
166,588
+3,039
+2% +$623K 0.17% 130
2019
Q3 		$34.6M Buy
163,549
+1,963
+1% +$410K 0.2% 110
2019
Q2 		$31.4M Sell
161,586
-3,280
-2% -$605K 0.18% 123
2019
Q1 		$27.1M Buy
164,866
+40
+0% +$7.07K 0.17% 130
2018
Q4 		$31M Buy
164,826
+2,459
+2% +$454K 0.23% 106
2018
Q3 		$27.6M Buy
162,367
+173
+0.1% +$29.1K 0.17% 133
2018
Q2 		$26.6M Buy
162,194
+2,444
+2% +$399K 0.18% 125
2018
Q1 		$25.8M Buy
159,750
+15,452
+11% +$2.46M 0.18% 122
2017
Q4 		$21.1M Buy
144,298
+4,194
+3% +$597K 0.14% 151
2017
Q3 		$19M Sell
140,104
-3,534
-2% -$446K 0.14% 157
2017
Q2 		$18M Sell
143,638
-11,185
-7% -$1.34M 0.14% 171
2017
Q1 		$18.7M Buy
154,823
+28,593
+23% +$3.44M 0.15% 157
2016
Q4 		$14.6M Buy
126,230
+19,262
+18% +$2.14M 0.13% 173
2016
Q3 		$11.2M Sell
106,968
-16,924
-14% -$1.77M 0.1% 204
2016
Q2 		$9.75M Buy
123,892
+23,313
+23% +$2.2M 0.09% 207
2016
Q1 		$9.66M Buy
100,579
+5,856
+6% +$533K 0.09% 202
2015
Q4 		$8.58M Buy
94,723
+6,184
+7% +$582K 0.08% 222
2015
Q3 		$8.21M Sell
88,539
-5,962
-6% -$567K 0.07% 249
2015
Q2 		$8.79M Sell
94,501
-13,821
-13% -$1.29M 0.01% 923
2015
Q1 		$10.3M Sell
108,322
-4,657
-4% -$431K 0.02% 848
2014
Q4 		$10M Buy
112,979
+26,643
+31% +$2.26M 0.02% 854
2014
Q3 		$6.9M Buy
86,336
+593
+0.7% +$44.7K 0.01% 947
2014
Q2 		$6.08M Buy
85,743
+362
+0.4% +$25.5K 0.01% 967
2014
Q1 		$6.32M Sell
85,381
-1,318
-2% -$99.4K 0.01% 923
2013
Q4 		$6.8M Sell
86,699
-181
-0.2% -$14.2K 0.01% 869
2013
Q3 		$6.42M Sell
86,880
-6,921
-7% -$510K 0.01% 841
2013
Q2 		$7.13M Buy
+93,801
New +$6.15M 0.01% 808

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company's CME Position: Q1 2026 in Review

William Blair & Company increased its CME Group (CME) stake by 38% in Q1 2026, buying an estimated $16.8M and bringing the position to 204,534 shares worth $60.4M. The position accounts for 0.17% of the portfolio, ranked #125.

William Blair & Company first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • William Blair & Company held 204,534 shares of CME Group worth $60.4M as of Q1 2026.
  • William Blair & Company bought 56,694 CME Group shares in Q1 2026, an estimated $16.8M.
  • CME Group made up 0.17% of William Blair & Company's portfolio in Q1 2026, its #125 holding.
  • William Blair & Company first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.